`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 1 of 4 PagelD: 8050
`
`Case 2:13-cv-00391-ES-JAD Document 445 Filed 05/10/18 Page 3 of 6 PagelD: 8046
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`LIMITED,
`
`v.
`
`Plaintiffs,
`
`AMNEAL PHARMACEUTICALS, LLC, et al.,
`
`Defendants.
`
`
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`
`
`
`
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`
`
`
`
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`
`
`
`
`
`
`LIMITED,
`
`v.
`
`Plaintiffs,
`
`AMNEAL PHARMACEUTICALS, LLC,
`
`Defendant.
`
`LIMITED,
`
`V.
`
`Plaintiffs,
`
`
`
`LUPIN LTD.,
`LUPIN PHARMACEUTICALS INC., and
`
`LUPIN INC,
`
`Defendants.
`
`Civil Action No. 13-391 (ES)(JAD)
`(Consolidated)
`
`(Filed Electronically)
`
`Civil Action No. 17-1440 (ES)(JAD)
`
`Civil Action No. 18-8267 (ES)( JAD)
`
`STIPULATION AND
`
`ORDER FOR CONSOLIDATION
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 2 of 4 PageID: 8051
`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 2 of 4 PageID: 8051
`Case 2:13-cv-00391-ES—JAD Document 445 Filed 05/10/18 Page 4 of 6 PageID: 8047
`
`WHEREAS Plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland
`
`Limited (collectively, “Jazz”) initiated Civil Action No. 17-1440-ES-JAD alleging infringement
`
`of United States Patent No. 9,486,426 (“the ’426 patent”) by Defendant Amneal
`
`Pharmaceuticals, LLC’s (“Amneal”) submission of Abbreviated New Drug Application
`
`(“ANDA”) No. 203631 to the United States Food and Drug Administration (“FDA”) for
`
`regulatory approval of a 500 mg/ml sodium oxybate oral solution;
`
`WHEREAS Plaintiffs Jazz initiated Civil Action No. 18-8267-ES-JAD alleging
`
`infringement of the ’426 patent by Defendants Lupin Ltd., Lupin Pharmaceuticals Inc., and
`
`Lupin Inc.’s (collectively, “Lupin”) submission of ANDA No. 207415 to the FDA for regulatory
`
`approval of a 500 mg/ml sodium oxybate oral solution;
`
`WHEREAS Civil Action Nos. 17-1440-ES-JAD and 18-8267-ES-JAD are substantially
`
`related to the consolidated litigation initiated by Jazz captioned Jazz Pharmaceuticals, Inc. et al.
`
`v. Amneal Pharmaceuticals LLC et al., Civil Action No. 13-391-ES-JAD (consolidated), which
`
`is before this Court;
`
`WHEREAS the parties have agreed to the consolidation of Civil Action Nos. 17-1440-
`
`ES-JAD and 18-8267-ES-JAD with Civil Action No. 13-391-ES-JAD (consolidated) for all
`
`purposes;
`
`WHEREAS the parties have agreed that their respective contentions concerning the
`
`infringement and validity of US. Patent Nos. 8,772,306 and 9,050,302 served in Civil Action
`
`No. 13-39l-ES-JAD shall apply equally to the ’426 patent and that additional contentions
`
`concerning the ’426 patent shall not be served following consolidation;
`
`WHEREAS the parties have agreed that no further fact discovery shall be taken in Civil
`
`Action No. l3-391-ES-JAD, including with respect to the ‘426 patent following consolidation;
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 3 of 4 PageID: 8052
`
`Case 2:13-cv-00391-ES—JAD Document 446 Filed 05/14/18 Page 3 of 4 PagelD: 8052
`
`Case 2:13-cv-00391-ES-JAD Document 445 Filed 05/10/18 Page 5 of 6 PageID: 8048
`
`WHEREAS the parties have agreed to be bound by the Discovery Confidentiality Order
`
`entered in Civil Action No. 13-391-ES-JAD (consolidated) under Docket Entry 335 or any
`
`subsequent amendments thereto;
`
`WHEREAS good cause exists to consolidate Civil Action Nos. 17-1440-ES-JAD and
`
`18-8267-ES-JAD with Civil Action No. l3-391-ES-JAD;
`
`WHEREFORE Jazz, Amneal, and Lupin, by and through their attorneys, respectfully
`
`request that this Court consolidate Civil Action Nos. 17-1440-ES-JAD and 18-8267-ES-JAD
`
`with Civil Action No. 13-391-ES-JAD for all purposes and that all of the papers in these
`
`consolidated actions should be filed and maintained in Civil Action No. 13-391-ES-JAD;
`
`Dated: May 10, 2018
`
`SO STIPULATED:
`
`st Charles M. Lizza
`Charles M. Lizza
`William C. Baton
`
`SAUL EWING ARNSTEIN & LEI-IR, LLP
`One Riverfront Plaza, Suite 1520
`
`Newark, New Jersey 07102-5426
`(973) 286-6700
`clizza@saul.com
`wbaton@saul.com
`
`OF COUNSEL:
`F. Dominic Cerrito
`
`Eric C. Stops
`Evangeline Shih
`Gabriel P. Brier
`
`Frank C. Calvosa
`
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue
`
`22nd Floor
`
`New York, New York 10010
`
`(212) 849-7000
`Richard G. Greco
`
`RICHARD G. GRECO PC
`
`s/ Paul H. Kochanski
`Paul H. Kochanski
`
`LERNER DAVID LITTENBERG KRUMHOLZ &
`
`MENTLIK, LLP
`600 South Avenue West
`
`Westfield, New Jersey 07090
`(908) 654-5000
`pkochanski@lernerdavid.com
`
`OF COUNSEL:
`Steven A. Maddox
`
`Matthew C. Ruedy
`Maddox Edwards PLLC
`
`1900 K Street NW —- Suite 725
`
`Washington, DC 20006
`(202) 830-0707
`
`Attorneys for Defendant
`Amneal Pharmaceuticals, LLC
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 4 of 4 PageID: 8053
`
`Case 2:13-cv-00391-ES-JAD Document 446 Filed 05/14/18 Page 4 of 4 PagelD: 8053
`Case 2:13-cv-00391-ES-JAD Document 445 Filed 05/10/18 Page 6 of 6 PagelD: 8049
`
`90 State Street, Suite 700
`Albany, New York 12207
`(212) 203-7625
`
`st Melissa E. Flax
`James E. Cecchi
`Melissa E. Flax
`Michael Cross
`
`Attorneys for Plaintiffs
`Jazz Pharmaceuticals, Inc. and
`Jazz Pharmaceuticals Ireland Limited
`
`CARELLA, BYRNE, CECC‘HI, OLSTEIN, BRODY &
`AGNELLO, PC
`5 Becker Farm Road
`
`Roseland, New Jersey 07068-1739
`(973) 994-1700
`JCecchi@carellabyme.com
`
`OF COUNSEL:
`
`William A. Rakoczy
`Paul J. Molino
`Deanne M. Mazzochi
`Jeff A. Marx
`Natasha L. White
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`6 West Hubbard Street, Suite 500
`
`Chicago, Illinois 60654
`(312) 527-2157
`
`Attorneys for Defendants
`Lupin Limited, Lupin Pharmaceuticals, Inc.
`and Lupin Inc.
`
`*3
`IT IS so ORDERED this >“x = day of
`
`
`Hon.J
`eph
`.Dickson,U.S.M.J
`
`cc: Hon. Esther Salas, U.S.D.J.
`
`